Prevalence and associated factors of dysglycemia among patients with chronic obstructive pulmonary disease

1. Decramer, M, Janssens, W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013; 1(1): 73–83.
Google Scholar | Crossref | Medline2. World Health Organization (WHO): Media Center/Fact Sheet, Diabetes Unit . Retrieved from: http://www.who.int/mediacentre/factsheets/fs312/en/
Google Scholar3. Loh, LC, Rashid, A, Sholehah, S, et al. Low prevalence of obstructive lung disease in a suburban population of Malaysia: a BOLD collaborative study. Respirology 2016; 21(6): 1055–1061.
Google Scholar | Crossref | Medline4. Group RCW . COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology (Carlton, Vic.) 2003; 8(2): 192.
Google Scholar | Crossref | Medline5. National Health and Morbidity Survey . (NHMS 2015) Vol. II: Non-Communicable Diseases Risk Factors & Other Health Problems. Kuala Lumpur, Malaysia: Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, 2015, Vol. 2.
Google Scholar6. Institute for Public Health (IPH), National Institutes of Health, Ministry of Health Malaysia . National Health and Morbidity Survey (NHMS) 2019: Vol. I: NCDs – Non-communicable Diseases: Risk Factors and Other Health Problems, 2020.
Google Scholar7. Lee, CT-C, Mao, I-C, Lin, CH, et al.. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population‐based study. Eur J Clin Invest 2013; 43(11): 1113–1119.
Google Scholar | Medline8. Yamane, T, Yokoyama, A, Kitahara, Y, et al. Cross-sectional and prospective study of the association between lung function and prediabetes. BMJ Open 2013; 3(2): e002179.
Google Scholar | Crossref | Medline9. Mekov, E, Slavova, Y, Genova, M, et al.. Diabetes mellitus type 2 in patients with COPD admitted for exacerbation: preliminary data. Eur Respir J 2014; 44(Suppl 58): P4102.
Google Scholar10. Mannino, DM, Thorn, D, Swensen, A, et al.. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32(4): 962–969.
Google Scholar | Crossref | Medline | ISI11. Mirrakhimov, AE . Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetology 2012; 11(1): 132.
Google Scholar | Crossref | Medline12. Baker, EH, Janaway, CH, Philips, BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61(4): 284–289.
Google Scholar | Crossref | Medline | ISI13. Forde, H, Egan, A, Farrell, S, et al.. The prevalence of diabetes and pre-diabetes in patients admitted to hospital with acute exacerbations of COPD. Irish J Of Med Sci 2013; 45(2):183–188.
Google Scholar14. Parappil, A, Depczynski, B, Collett, P, et al.. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology 2010; 15(6): 918–922.
Google Scholar | Crossref | Medline | ISI15. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD, Inc, 2016, http://goldcopd.org.
Google Scholar16. Academy of Medicine of Malaysia . Malaysian Association for the Study of Obesity, Malaysian Endocrine and Metabolic Society, and the Ministry of Health, Malaysia. Clinical Practice Guidelines on the Management of Obesity. MOH (Malaysia), 2004, www.moh.gov.my/.
Google Scholar17. Malaysian Clinical Practice Guidelines on Management of Type 2 Diabetes Mellitus (5th Edition) 2015: Ministry of Health Malaysia. https://www.moh.gov.my/moh/resources/Penerbitan/CPG/Endocrine/3a.pdf
Google Scholar18. SSSL . Comparing 2 Proportion Sample Size, 2016. Retrieved from, https://select-statistics.co.uk/calculators/sample-size-calculator-two-proportions/
Google Scholar19. Ban, A, Ismail, A, Harun, R, et al.. Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation. BMC Pulm Med 2012; 12(1): 27.
Google Scholar | Crossref | Medline | ISI20. Al Aqqad, S, Ali, HI, Tangiisuran, B. Diabetes mellitus among patients admitted for acute exacerbation of COPD in Northern Malaysia. Int J Pharm Pract 2014; 22: 2.
Google Scholar21. Lim, S, Lam, DC-L, Muttalif, AR, et al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med 2015; 14(1): 4.
Google Scholar | Crossref | Medline22. Mekov, EV, Slavova, YG, Genova, MP, et al. Diabetes mellitus type 2 in hospitalized COPD patients: impact on quality of life and lung function. Folia Med 2016; 58(1): 36–41.
Google Scholar | Crossref23. Fine, MJ, Smith, MA, Carson, CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996; 275(2): 134–141.
Google Scholar | Crossref | Medline24. Rogliani, P, Calzetta, L, Segreti, A, et al. Diabetes mellitus among outpatients with COPD attending a university hospital. Acta Diabetol 2014; 51(6): 933–940.
Google Scholar | Crossref | Medline | ISI25. Parappil, A, Depczynski, B, Collett, P, et al.. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology 2010; 15(6): 918–922.
Google Scholar | Crossref | Medline | ISI26. Walters, JA, Gibson, PG, Wood-Baker, R, et al.. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001288. doi: 10.1002/14651858.CD001288.pub4
Google Scholar | Crossref27. Habib, G, Dar-Esaif, Y, Bishara, H, et al. The impact of corticosteroid treatment on hemoglobin A1C levels among patients with type-2 diabetes with chronic obstructive pulmonary disease exacerbation. Resp Med 2014; 108(11): 1641–1646.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif